{
    "id": 301953,
    "brand": "dep",
    "name": "DEP® cabazitaxel",
    "slug": "dep-cabazitaxel",
    "description": "DEP® cabazitaxel is Starpharma’s detergent-free version of cancer drug, Jevtana®, which is marketed by Sanofi Aventis to treat advanced prostate cancer, and is also under clinical development for a range of other cancer types, including testicular, ovarian, breast, bladder, and head and neck.\r\n",
    "company_name": "DNT (Starpharma Group)",
    "company_slug": "dnt-starpharma-group",
    "logo_url": "https://media.knowde.com/image/upload/f_auto,q_auto,w_128/v1664289376/production/Company/24188/logo/image.png",
    "banner_url": "https://media.knowde.com/image/upload/v1625608850/production/CategoryImage/582/category_image/HealthcarePharma_04.jpg",
    "properties": {
        "Applications": [
            "Medical",
            "Other Medical Applications"
        ],
        "Product Families": [
            "APIs & Raw Materials",
            "Active Pharmaceutical Ingredients (APIs)"
        ]
    },
    "summary": {}
}